Timelex
ActiveSummary
Timelex has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.1m and a net result of €44,021. Equity is growing by about 5.7% per year across the filed financial years. Its solvency ranks better than 52% of 4,102 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Financials · financial year 2025, abbreviated format
Equity
€1.1m▲ 4.3%
2024 · €1.0m
Total assets
€2.4m▲ 5.5%
2024 · €2.2m
Net result
€44,021▼ 4.1%
2024 · €45,907
Working capital
€2.0m▲ 16.7%
2024 · €1.7m
Trend over the years
2021 to 2025, 5 financial years 2019 to 2025, 7 financial years
The operating result has fallen three years in a row; 2025 is 15% below 2024 and is the lowest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result€0.06m
2025
Net result€0.04m
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€2.4m
2025
Equity€1.1m
2025
Debt€1.3m
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€2.0m
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)1.9%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency45.9%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio7.42
2025
Average staff in full-time equivalents (FTE).
Staff (FTE)3.6
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 69, Legal and accounting activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the financial year before
favourable
unfavourable
Line2019202020212022202320242025
Operating result€0.1m-€0.08m▼ 38.1%€0.08m▲ 6.6%€0.09m▲ 11.4%€0.09m▼ 4.2%€0.07m▼ 17.6%€0.06m▼ 14.7%
Net result€0.08m-€0.05mwithin the sector's middle half▼ 39.5%€0.06mwithin the sector's middle half▲ 22.9%€0.06mwithin the sector's middle half▼ 0.1%€0.06mwithin the sector's middle half▼ 4.7%€0.05mwithin the sector's middle half▼ 18.0%€0.04mwithin the sector's middle half▼ 4.1%
Equity€0.8m-€0.8mabove the sector's middle half▲ 6.2%€0.9mabove the sector's middle half▲ 7.2%€0.9mabove the sector's middle half▲ 6.7%€1.0mabove the sector's middle half▲ 6.0%€1.0mabove the sector's middle half▲ 4.6%€1.1mabove the sector's middle half▲ 4.3%
Total assets€2.2m-€1.8mwithin the sector's middle half▼ 16.4%€2.1mwithin the sector's middle half▲ 15.2%€1.7mwithin the sector's middle half▼ 17.4%€3.3mabove the sector's middle half▲ 92.7%€2.2mwithin the sector's middle half▼ 33.2%€2.4mabove the sector's middle half▲ 5.5%
Debt€1.4m-€1.0m▼ 28.7%€1.2m▲ 21.6%€0.8m▼ 34.7%€2.3m▲ 194%€1.2m▼ 49.1%€1.3m▲ 6.6%
Working capital€0.9m-€1.0mabove the sector's middle half▲ 12.4%€1.7mabove the sector's middle half▲ 62.1%€1.3mabove the sector's middle half▼ 23.9%€2.5mabove the sector's middle half▲ 101%€1.7mabove the sector's middle half▼ 32.4%€2.0mabove the sector's middle half▲ 16.7%
Solvency35.2%-44.8%within the sector's middle half▲ 9.5pp41.7%within the sector's middle half▼ 3.1pp53.9%within the sector's middle half▲ 12.2pp29.6%within the sector's middle half▼ 24.2pp46.4%within the sector's middle half▲ 16.8pp45.9%within the sector's middle half▼ 0.5pp
Current ratio1.81-2.46within the sector's middle half▲ 0.645.46above the sector's middle half▲ 3.003.92above the sector's middle half▼ 1.544.29above the sector's middle half▲ 0.374.54above the sector's middle half▲ 0.257.42above the sector's middle half▲ 2.87
Return on assets (ROA)3.6%-2.6%within the sector's middle half▼ 1.0pp2.8%within the sector's middle half▲ 0.2pp3.4%within the sector's middle half▲ 0.6pp1.7%below the sector's middle half▼ 1.7pp2.1%below the sector's middle half▲ 0.4pp1.9%below the sector's middle half▼ 0.2pp
Staff (FTE)1.2-2.9within the sector's middle half▲ 142%3.3within the sector's middle half▲ 13.8%3within the sector's middle half▼ 9.1%3.3within the sector's middle half▲ 10.0%3.3within the sector's middle half=3.6within the sector's middle half▲ 9.1%
above
within
below
the middle half of NACE 69, Legal and accounting activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.4m
Fixed assets
€42,345 ▲ 23.8%
Current assets
€2.3m ▲ 5.2%
Equity and liabilities €2.4m
Equity
€1.1m ▲ 4.3%
Debt
€1.3m ▲ 6.6%
Debt's share of the balance-sheet total rises from 53.6% to 54.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€73,282▼
2024 · €83,654
Cash flow
€56,423▼
2024 · €58,224
Debt to equity
1.18▲
2024 · 1.15
ROE
4.1%▼
2024 · 4.4%
Debt ≤ 1 year
€311,227▼
2024 · €482,917
Income taxes
€19,638▼
2024 · €26,212
Staff costs
€234,939▲
2024 · €228,915
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 10,905 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95.1% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit under 5% of the balance sheet
0.7%
went bankrupt
4.0%
stopped otherwise
95.1%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,474 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 10,905 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | - | €184,246 | €220,159 | €228,915 | €234,939 | ▲ 2.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €72,577 | €62,820 | €43,372 | €39,771 | €21,031 | €12,317 | €12,403 | ▲ 0.7% |
| Other operating charges640/8 | - | - | - | €1,083 | €84,024 | €1,045 | €1,055 | ▲ 0.9% |
| Gross operating margin9900 | €266,009 | €284,349 | €332,453 | €315,440 | €411,782 | €313,614 | €309,276 | ▼ 1.4% |
| Operating profit (loss)9901 | €122,934 | €76,073 | €81,110 | €90,340 | €86,569 | €71,338 | €60,879 | ▼ 14.7% |
| Financial income75/76B | - | - | - | €938 | €1,951 | €2,267 | €2,780 | ▲ 22.6% |
| Recurring financial income75 | €21 | €1,028 | €691 | €938 | €1,951 | €2,267 | €2,780 | ▲ 22.6% |
| Financial charges65/66B | - | - | - | €2,989 | €2,531 | €1,485 | - | - |
| Recurring financial charges65 | €2,375 | €35 | €176 | €2,989 | €2,531 | €1,485 | - | - |
| Profit (loss) for the period before taxes9903 | €120,581 | €77,067 | €81,625 | €88,288 | €85,989 | €72,120 | €63,659 | ▼ 11.7% |
| Income taxes67/77 | €41,427 | €29,214 | €22,823 | €29,533 | €30,021 | €26,212 | €19,638 | ▼ 25.1% |
| Profit (loss) for the period9904 | €79,154 | €47,852 | €58,802 | €58,755 | €55,968 | €45,907 | €44,021 | ▼ 4.1% |
| Profit (loss) for the period to be appropriated9905 | €79,154 | €47,852 | €58,802 | €58,755 | €55,968 | €45,907 | €44,021 | ▼ 4.1% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €2.2m | €1.8m | €2.1m | €1.7m | €3.3m | €2.2m | €2.4m | ▲ 5.5% |
| Fixed assets21/28 | €0.1m | €0.1m | €0.07m | €0.04m | €0.04m | €0.03m | €0.04m | ▲ 23.8% |
| Tangible fixed assets22/27 | €0.1m | €0.09m | €0.06m | €0.03m | €0.02m | €0.02m | €0.03m | ▲ 36.9% |
| Plant, machinery and equipment23 | - | - | - | €0.01m | €0.02m | €0.02m | €0.02m | ▲ 43.6% |
| Furniture and vehicles24 | - | - | - | €0.008m | €0.005m | €0.004m | €0.002m | ▼ 41.3% |
| Leasing and similar rights25 | - | - | - | €0.01m | €0.002m | €0.001m | €0.003m | ▲ 203% |
| Financial fixed assets28 | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | €0.01m | = |
| Current assets29/58 | €2.0m | €1.7m | €2.0m | €1.7m | €3.3m | €2.2m | €2.3m | ▲ 5.2% |
| Amounts receivable within one year40/41 | €1.3m | €0.9m | €0.8m | €0.9m | €1.4m | €1.3m | €1.2m | ▼ 6.8% |
| Trade receivables40 | - | - | - | €0.8m | €1.2m | €1.1m | €1.1m | ▲ 1.0% |
| Other amounts receivable41 | - | - | - | €0.08m | €0.2m | €0.2m | €0.1m | ▼ 48.1% |
| Current investments50/53 | - | - | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Cash at bank and in hand54/58 | €0.7m | €0.8m | €1.3m | €0.8m | €1.9m | €0.9m | €1.1m | ▲ 22.1% |
| Deferred charges and accrued income490/1 | - | - | - | - | - | - | €0.002m | - |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €2.2m | €1.8m | €2.1m | €1.7m | €3.3m | €2.2m | €2.4m | ▲ 5.5% |
| Equity10/15 | €0.8m | €0.8m | €0.9m | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Contributions10/11 | €0.006m | €0.006m | - | €0.006m | €0.006m | €0.006m | €0.006m | = |
| Reserves13 | €0.8m | €0.8m | €0.9m | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Non-distributable reserves130/1 | - | - | - | €0.002m | - | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €0.002m | - | - | - | - |
| Distributable reserves133 | - | - | - | €0.9m | €1.0m | €1.0m | €1.1m | ▲ 4.3% |
| Amounts payable17/49 | €1.4m | €1.0m | €1.2m | €0.8m | €2.3m | €1.2m | €1.3m | ▲ 6.6% |
| Amounts payable within one year42/48 | €1.1m | €0.7m | €0.4m | €0.4m | €0.8m | €0.5m | €0.3m | ▼ 35.6% |
| Trade debts44 | €1.1m | €0.7m | €0.3m | €0.4m | €0.7m | €0.5m | €0.3m | ▼ 37.4% |
| Suppliers440/4 | - | - | - | €0.4m | €0.7m | €0.5m | €0.3m | ▼ 37.4% |
| Taxes, remuneration and social security45 | - | - | - | €0.03m | €0.04m | €0.02m | €0.02m | ▲ 3.6% |
| Taxes450/3 | - | - | - | €0.01m | €0.01m | €0.006m | - | - |
| Remuneration and social security454/9 | - | - | - | €0.02m | €0.03m | €0.02m | €0.02m | ▲ 39.2% |
| Accrued charges and deferred income492/3 | - | - | - | €0.4m | €1.6m | €0.7m | €1.0m | ▲ 35.2% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €0.08m | €0.05m | €0.06m | €0.06m | €0.06m | €0.05m | €0.04m | ▼ 4.1% |
| + Depreciation and write-downs630 | €0.07m | €0.06m | €0.04m | €0.04m | €0.02m | €0.01m | €0.01m | ▲ 0.7% |
| Operating cash flow (approximation) | €0.2m | €0.1m | €0.1m | €0.1m | €0.08m | €0.06m | €0.06m | ▼ 3.1% |
| Investment in fixed assets (approximation) | - | -€0.01m | -€0.02m | -€0.01m | -€0.02m | -€0.01m | -€0.02m | ▼ 96.1% |
| Change in cash | - | €0.09m | €0.5m | -€0.5m | €1.1m | -€1.0m | €0.2m | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 18 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | abbreviated format | 30-01-2026 | 2026-00021428 |
| 30-06-2024 | abbreviated format | 31-01-2025 | 2025-00017908 |
| 30-06-2023 | abbreviated format | 31-01-2024 | 2024-00015505 |
| 30-06-2022 | abbreviated format | 27-01-2023 | 2023-00006073 |
| 30-06-2021 | abbreviated format | 31-01-2022 | 2022-03500407 |
| 30-06-2020 | abbreviated format | 29-01-2021 | 2021-02900195 |
| 30-06-2019 | abbreviated format | 29-01-2020 | 2020-02700155 |
| 30-06-2018 | abbreviated format | 31-01-2019 | 2019-03700339 |
| 30-06-2017 | abbreviated format | 31-01-2018 | 2018-03700519 |
| 30-06-2016 | abbreviated format | 30-01-2017 | 2017-03000025 |
Similar companies · same sector, comparable size
RAINGHOUTS
BE 0819.391.464
Elsene · equity €1,078,888
Advocatenkantoor Katleen Tobback
BE 0812.144.574
Leuven · equity €1,079,811
Juhi Dion Sud
BE 0650.877.126
Brussel · equity €1,076,609
LUC DE MEYERE
BE 0872.900.228
Sint-Laureins · equity €1,080,848
TVO management
BE 0535.998.541
Hasselt · equity €1,085,781
Of the 22,302 active companies whose main activity is activities of lawyers (NACE 69101), figures are known for 9,353. 4,142 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Subsidies and aid
European Union, budget
2021 to 2025 · 81 entries · €8.3m in total| Year | Entries | Awarded |
|---|---|---|
| 2025 | 9 | €1.2m |
| 2024 | 11 | €1.3m |
| 2023 | 17 | €1.8m |
| 2022 | 29 | €3.3m |
| 2021 | 15 | €0.6m |
Projects
AISYM4MED - SYNTHETIC AND SCALABLE DATA PLATFORM FOR MEDICAL EMPOWERED AI
CARAMEL - CARDIOVASCULAR RISK ASSESSMENT IN MENOPAUSAL WOMEN VIA MULTIMODAL DATA ANALYSIS ENABLING PERSONALIZED PREVENTION STRATEGIES
POSEIDON - POST-QUANTUM SECURE DIGITAL IDENTITIES FOR EUROPEAN SOLUTIONS
PREVENT - IMPROVING AND UPSCALING PRIMARY PREVENTION OF CANCER BY ADDRESSING CHILDHOOD OBESITY THROUGH IMPLEMENTATION RESEARCH - THE PREVENT APPROACH
CYCLOPS - AUTOMATED END-TO-END DATA LIFE CYCLE MANAGEMENT FOR FAIR DATA INTEGRATION, PROCESSING AND RE-USE
Show 28 more projects
101073949 2PS PREVENT & PROTECT THROUGH SUPPORT AIMS TO OFFER A PARADIGM SHIFT IN THE APPROACH TACKLING CHILD SEXUAL ABUSE AND EXPLOITATION ACROSS EUROPE WITH PREVENTIVE ACTIONS ADDRESSING PEOPLE WHO ARE OR COULD BE A THREAT TO CHILDREN
DISARMING THE SILENT THREAT OF OVARIAN CANCER
VOLABIOS - VALIDATION AND COMPARITIVE MULTI-OMICS BENCHMARKING OF FLUID-DERIVED VOLATILOMICS BIOMARKERS FOR THE PREVENTION AND EARLY DETECTION OF SCHIZOPHRENIA
RES-Q PLUS - COMPREHENSIVE SOLUTIONS OF HEALTHCARE IMPROVEMENT BASED ON THE GLOBAL REGISTRY OF STROKE CARE QUALITY
TRUMPET - TRUSTWORTHY MULTI-SITE PRIVACY ENHANCING TECHNOLOGIES
ENDURANCE - STRATEGIES AND SERVICES FOR ENHANCED DISRUPTION RESILIENCE AND COOPERATION IN EUROPE
LETS CARE - LETS CARE: BUILDING SAFE AND CARING SCHOOLS TO FOSTER EDUCATIONAL INCLUSION AND SCHOOL ACHIEVEMENT
EMPOWERING AND CONNECTING DIVERSE COMMUNITIES FOR MULTI-HAZARD RESILIENCE WITH OPEN DATA, OPEN MODELS, AND OPEN-SOURCE SOFTWARE
FLUTE - FEDERATE LEARNING AND MULTI-PARTY COMPUTATION TECHNIQUES FOR PROSTATE CANCER
TRIDENT - TECHNOLOGY BASED IMPACT ASSESSMENT TOOL FOR SUSTAINABLE, TRANSPARENT DEEP SEA MINING EXPLORATION AND EXPLOITATION
AI4LUNGS - AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
REBECCA - RESEARCH ON BREAST CANCER INDUCED CHRONIC CONDITIONS SUPPORTED BY CAUSAL ANALYSIS OF MULTI-SOURCE DATA
TRACY - A BIG-DATA ANALYTICS FROM BASE-STATIONS REGISTRATIONS AND CDRS E-EVIDENCE SYSTEM
CONVINCE - CONTEXT-AWARE VERIFIABLE DYNAMIC DELIBERATION
ONCOSCREEN - A EUROPEAN SHIELD AGAINST COLORECTAL CANCER BASED ON NOVEL, MORE PRECISE AND AFFORDABLE RISK-BASED SCREENING METHODS AND VIABLE POLICY PATHWAYS
TOLIFE - COMBINING ARTIFICIAL INTELLIGENCE AND SMART SENSING TOWARD BETTER MANAGEMENT AND IMPROVED QUALITY OF LIFE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
INCIDENTRON - MASTERING INCIDENT RESPONSE THROUGH AN OPEN SOURCE FRAMEWORK, ARCHITECTURE, AND PLATFORM
DOME - A DISTRIBUTED OPEN MARKETPLACE FOR EUROPE CLOUD AND EDGE SERVICES
LUCIA - UNDERSTANDING LUNG CANCER RELATED RISK FACTORS AND THEIR IMPACT
AIRCARE - AI-AUGMENTED ROBOTICS FOR CANCER POINT OF CARE
CYBERSEAS - CYBERSEAS: CYBER SECURING ENERGY DATA SERVICES
GLIOMATCH - THE MALIGNANT GLIOMA IMMUNO-ONCOLOGY MATCHMAKER: TOWARDS DATA-DRIVEN PRECISION MEDICINE USING SPATIALLY RESOLVED RADIO-MULTIOMICS
IMPACT- AML - MASTER FRAMEWORK AND PRAGMATIC CLINICAL TRIAL FOR RELAPSE OR REFRACTORY ACUTE MYELOID LEUKEMIA
KOBAN - IDENTIFYING FUTURE CAPABILITIES FOR COMMUNITY POLICING
TRUSTCHAIN - FOSTERING A HUMAN-CENTERED, TRUSTWORTHY AND SUSTAINABLE INTERNET
HOPLITE THREAT DETECTION AND INTELLIGENCE SHARING
AVIATOR PHASE 2 - AVIATOR - AUGMENTED VISUAL INTELLIGENCE AND TARGETED ONLINE RESEARCH
REGACE - CROP RESPONSIVE GREENHOUSE AGRIVOLTAICS SYSTEM WITH CO2 ENRICHMENT FOR HIGHER YIELDS
European research
65 projects · €14.9m EU contributionProgrammes
Projects
Mechanism-Informed Multimodal Generative AI for Causal and Dynamical Modelling in Biomedical Research
Synthetic and scalable data platform for medical empowered AI
Central Repository for Digital Pathology
AI-GENERATED DIGITAL TWIN INFRASTRUCTURE FOR HEALTHCARE & LIVING ENVIRONMENT
CArdiovascular Risk Assessment in MEnopausaL women via multimodal data analysis enabling personalized prevention strategies
Show 35 more projects
Improving and upscaling primary prevention of cancer by addressing childhood obesity through implementation research - the PREVENT approach
EMPOWERING AND EDUCATING YOUNG PEOPLE FOR THE INTERNET BY PLAYING
A multimodal AI-based toolbox and an interoperable health imaging repository for the empowerment of imaging analysis related to the diagnosis, prediction and follow-up of cancer
AEGLE (Ancient Greek: Αἴγλη) – An analytics framework for integrated and personalized healthcare services in Europe
POst-quantum SEcure dIgital iDentities for EurOpean solutioNs
FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE
Federate Learning and mUlti-party computation Techniques for prostatE cancer
Lightweight Infrastructure for Global Heterogeneous Trust management in support of an open Ecosystem of Stakeholders and Trust schemes.
Disarming the silent threat of ovarian cancer
Understanding Lung Cancer related risk factors and their Impact
Validation and Comparitive Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early detection of Schizophrenia
Automated end-to-end data life cycle management for FAIR data integration, processing and re-use
2PS - Prevent & Protect Through Support
Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality
From mobile phones to court – A complete FORensic investigation chain targeting MOBILE devices
TRUstworthy Multi-site Privacy Enhancing Technologies
KONFIDO - Secure and Trusted Paradigm for Interoperable eHealth Services
ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY
Design of the European mobile network operator for research
AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION
A European “shield” against colorectal cancer based on novel, more precise and affordable risk-based screening methods and viable policy pathways
DEvOps for trusted, portable and interoperable Multi-Cloud applications towards the Digital singlE market
Strategies and Services for Enhanced Disruption Resilience and Cooperation in Europe
Mobile Cross-Border Government Services for Europe
The malignant Glioma immuno-oncology matchmaker: towards data-driven precision medicine using spatially resolved radio-multiomics
Empowering and Connecting Diverse Communities for Multi-Hazard Resilience with Open Data, Open Models, and Open-Source Software
Technology based impact assessment tool foR sustaInable, transparent Deep sEa miNing exploraTion and exploitation
REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data
Digital Europe for All
NOVEL INTEGRATED SOLUTION OF OPERATING A FLEET OF DRONES WITH MULTIPLE SYNCHRONIZED MISSIONS FOR DISASTER RESPONSES
A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment.
Next-Generation Visuohaptic Media Representation, Coding and Interactive Rendering for Immersive and Inclusive XR
implemented SynergIes, data sharing contracts and Goals between transport modes and AIR tansportation
CONtext-aware VerifIable dyNamiC dEliberation
Combining Artificial Intelligence and smart sensing TOward better management and improved quality of LIFE in chronic obstructive pulmonary disease
Public contracts
5 awards · 2022 to 2026
Juridische adviesverlening en ondersteuning.: 2025/HFB/VOPMB/139729 - 6
Juridische adviesverlening en ondersteuning.: 2025/HFB/VOPMB/139729 - 7
Supporting ENISA in ensuring Cyber Resilience of the EU: Cybersecurity Support and Compliance for SMEs under the Cyber Resilience Act
Procédure ouverte pour la « prestation de services juridiques par des avocats dans des procédures devant la Chambre contentieuse de l'Autorité de protection des données et la Cour des marchés »: Nederlandstalige zaken
2021/HFB/VOPMB/80868 - Raamovereenkomst voor juridische ondersteuning.: Perceel 6
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. Values as the buyer published them; for a framework agreement, a ceiling.